S Kant Healthcare is a finished-dose manufacturer based in India. It appears in 134 regulatory filings across 8 regulators, without an active US DMF or CEP on file. Its filings concentrate with TMDA (TZ), NAFDAC (NG) and EFDA (ET). Its GMP standing is certified by NAFDAC (NG), FDA (GH) and TMDA (TZ), among 4 authorities. Customs aggregates show $46.5M of exports covering 1,092 molecules to 66 destinations in 2025.
| Site | FDA FEI |
|---|---|
| Vapi, India | Not on file |
| Gujarat State, Nigeria | Not on file |
| Regulator | Filings | GMP certificates |
|---|---|---|
| TMDA (TZ) | 55 | 1 |
| NAFDAC (NG) | 26 | 2 |
| EFDA (ET) | 25 | None |
| DIGEMAPS (DO) | 18 | None |
| UZPHARM (UZ) | 4 | None |
| MINSA (CR) | 3 | None |
| FDA (GH) | None | 1 |
| EMA | None | 1 |
| Year | Revenue | Exports | Destinations |
|---|---|---|---|
| 2026 YTD | Not reported | $13.0M | 28 |
| 2025 | Not reported | $46.5M | 66 |
| 2024 | Not reported | $44.7M | 54 |
| 2023 | Not reported | $39.8M | 51 |
Export figures are customs aggregates. We do not publish the identity of any buyer.
Choose your molecules and target markets. S Kant Healthcare comes back tiered against every other supplier able to file there.
Start for free